Monkeypox: disease epidemiology, host immunity and clinical interventions
Open accessThe DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
Monkeypox virus (MPXV), which causes disease in humans, has for many years been restricted to the African continent, with only a handful of sporadic cases in other parts of the world. However, unprecedented outbreaks of monkeypox in non-endemic regions have recently taken the world by surprise. In less than 4 months, the number of detected MPXV infections has soared to more than 48,000 cases, recording a total of 13 deaths. In this Review, we discuss the clinical, epidemiological and immunological features of MPXV infections. We also highlight important research questions and new opportunities to tackle the ongoing monkeypox outbreak. In this Review, Ng and colleagues examine the clinical, epidemiological and immunological aspects of monkeypox virus (MPXV) infections, with a focus on mechanisms of host immunity to MPXV. The authors also consider the unique epidemiological and pathological characteristics of the current non-endemic outbreak of the virus and discuss vaccines, therapeutics and outstanding research questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
The NF- B Family of Transcription Factors and Its Regulation
Oeckinghaus, A., & Ghosh, S. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000034 · Cited by 2,842
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
Thornhill, J. P., Barkati, S., Walmsley, S., Rockstroh, J., Antinori, A., Harrison, L. B., Palich, R., Nori, A., Reeves, I., Habibi, M. S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2207323 · Cited by 2,148
The changing epidemiology of human monkeypox—A potential threat? A systematic review
Bunge, E. M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer, L. R., & Steffen, R. (2022) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0010141 · Cited by 1,936
A guide to vaccinology: from basic principles to new developments
Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593
Clinical features and management of human monkeypox: a retrospective observational study in the UK
Adler, H., Gould, S., Hine, P., Snell, L. B., Wong, W., Houlihan, C. F., Osborne, J. C., Rampling, T., Beadsworth, M. B., Duncan, C. J., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00228-6 · Cited by 1,256
McCollum, A. M., & Damon, I. K. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit703 · Cited by 1,086
Sanjuán, R., & Domingo-Calap, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2299-6 · Cited by 947
Duration of antiviral immunity after smallpox vaccination
Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M., & Slifka, M. K. (2003) · Nature Medicine · doi:10.1038/nm917 · Cited by 946
Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report
Yinka-Ogunleye, A., Aruna, O., Dalhat, M., Ogoina, D., McCollum, A., Disu, Y., Mamadu, I., Akinpelu, A., Ahmad, A., Burga, J., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30294-4 · Cited by 919
Rimoin, A. W., Mulembakani, P. M., Johnston, S. C., Lloyd Smith, J. O., Kisalu, N. K., Kinkela, T. L., Blumberg, S., Thomassen, H. A., Pike, B. L., Fair, J. N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005769107 · Cited by 876
A tale of two clades: monkeypox viruses
Likos, A. M., Sammons, S. A., Olson, V. A., Frace, A. M., Li, Y., Olsen-Rasmussen, M., Davidson, W., Galloway, R., Khristova, M. L., Reynolds, M. G., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.81215-0 · Cited by 865
Isidro, J., Borges, V., Pinto, M., Sobral, D., Santos, J. D., Nunes, A., Mixão, V., Ferreira, R., Santos, D., Duarte, S., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01907-y · Cited by 822
Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution
Alakunle, E., Moens, U., Nchinda, G., & Okeke, M. I. (2020) · Viruses · doi:10.3390/v12111257 · Cited by 812
Mucosal vaccines — fortifying the frontiers
Lavelle, E. C., & Ward, R. W. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00583-2 · Cited by 752
Cutting edge: long-term B cell memory in humans after smallpox vaccination
Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4969 · Cited by 695
Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans
Sklenovská, N., & Ranst, M. A. V. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00241 · Cited by 655
The Transmission Potential of Monkeypox Virus in Human Populations
FINE, P. E. M., JEZEK, Z., GRAB, B., & DIXON, H. (1988) · International Journal of Epidemiology · doi:10.1093/ije/17.3.643 · Cited by 648
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
Miller, J. D., van der Most, R. G., Akondy, R. S., Glidewell, J. T., Albott, S., Masopust, D., Murali-Krishna, K., Mahar, P. L., Edupuganti, S., Lalor, S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.020 · Cited by 601
Antinori, A., Mazzotta, V., Vita, S., Carletti, F., Tacconi, D., Lapini, L. E., D’Abramo, A., Cicalini, S., Lapa, D., Pittalis, S., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.22.2200421 · Cited by 561
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin
Chen, N., Li, G., Liszewski, M. K., Atkinson, J. P., Jahrling, P. B., Feng, Z., Schriewer, J., Buck, C., Wang, C., Lefkowitz, E. J., et al. (2005) · Virology · doi:10.1016/j.virol.2005.05.030 · Cited by 533
McFadden, G. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1099 · Cited by 523
Precopio, M. L., Betts, M. R., Parrino, J., Price, D. A., Gostick, E., Ambrozak, D. R., Asher, T. E., Douek, D. C., Harari, A., Pantaleo, G., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062363 · Cited by 488
Chang, H. W., Watson, J. C., & Jacobs, B. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4825 · Cited by 483
Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018
Vaughan, A., Aarons, E., Astbury, J., Brooks, T. J. G., Chand, M. A., Flegg, P. J., Hardman, A., Harper, N., Jarvis, R., Mawdsley, S., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2604.191164 · Cited by 456
Edghill-Smith, Y., Golding, H., Manischewitz, J., King, L. R., Scott, D., Bray, M., Nalca, A., Hooper, J. W., Whitehouse, C. A., Schmitz, J. E., et al. (2005) · Nature Medicine · doi:10.1038/nm1261 · Cited by 452
Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies
Thakur, A., Mikkelsen, H., & Jungersen, G. (2019) · Journal of Immunology Research · doi:10.1155/2019/1356540 · Cited by 396
Human monkeypox and smallpox viruses: genomic comparison
Shchelkunov, S. N., Totmenin, A. V., Babkin, I. V., Safronov, P. F., Ryazankina, O. I., Petrov, N. A., Gutorov, V. V., Uvarova, E. A., Mikheev, M. V., Sisler, J. R., et al. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03144-1 · Cited by 394
Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
Bukowski, J. F., Woda, B. A., Habu, S., Okumura, K., & Welsh, R. M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.3.1531 · Cited by 394
Re-emergence of monkeypox in Africa: a review of the past six years
Heymann, D. L., Szczeniowski, M., & Esteves, K. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011720 · Cited by 387
Colamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A., & Buller, R. M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.15974 · Cited by 386
Mbala, P. K., Huggins, J. W., Riu-Rovira, T., Ahuka, S. M., Mulembakani, P., Rimoin, A. W., Martin, J. W., & Muyembe, J.-J. T. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix260 · Cited by 379
Analysis of the Monkeypox Virus Genome
Shchelkunov, S. N., Totmenin, A. V., Safronov, P. F., Mikheev, M. V., Gutorov, V. V., Ryazankina, O. I., Petrov, N. A., Babkin, I. V., Uvarova, E. A., Sandakhchiev, L. S., et al. (2002) · Virology · doi:10.1006/viro.2002.1446 · Cited by 370
Local and systemic responses to SARS-CoV-2 infection in children and adults
Yoshida, M., Worlock, K. B., Huang, N., Lindeboom, R. G. H., Butler, C. R., Kumasaka, N., Dominguez Conde, C., Mamanova, L., Bolt, L., Richardson, L., et al. (2022) · Nature · doi:10.1038/s41586-021-04345-x · Cited by 365
Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion
Engelmayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I., Steinman, R. M., & Bhardwaj, N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6762 · Cited by 365
Regulating IRFs in IFN Driven Disease
Jefferies, C. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00325 · Cited by 365
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity
Smith, G. L., Benfield, C. T. O., Maluquer de Motes, C., Mazzon, M., Ember, S. W. J., Ferguson, B. J., & Sumner, R. P. (2013) · Journal of General Virology · doi:10.1099/vir.0.055921-0 · Cited by 364
Poxviruses Deploy Genomic Accordions to Adapt Rapidly against Host Antiviral Defenses
Elde, N. C., Child, S. J., Eickbush, M. T., Kitzman, J. O., Rogers, K. S., Shendure, J., Geballe, A. P., & Malik, H. S. (2012) · Cell · doi:10.1016/j.cell.2012.05.049 · Cited by 360
A27L Protein Mediates Vaccinia Virus Interaction with Cell Surface Heparan Sulfate
Chung, C.-S., Hsiao, J.-C., Chang, Y.-S., & Chang, W. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1577-1585.1998 · Cited by 355
Komiyama, T., Ray, C. A., Pickup, D. J., Howard, A. D., Thornberry, N. A., Peterson, E. P., & Salvesen, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32171-3 · Cited by 351
Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
Kotwal, G. J., & Moss, B. (1988) · Nature · doi:10.1038/335176a0 · Cited by 346
Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo
Kugelman, J. R., Johnston, S. C., Mulembakani, P. M., Kisalu, N., Lee, M. S., Koroleva, G., McCarthy, S. E., Gestole, M. C., Wolfe, N. D., Fair, J. N., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2002.130118 · Cited by 345
Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo
Norbury, C. C., Malide, D., Gibbs, J. S., Bennink, J. R., & Yewdell, J. W. (2002) · Nature Immunology · doi:10.1038/ni762 · Cited by 342
Cytokine Milieu of Atopic Dermatitis Skin Subverts the Innate Immune Response to Vaccinia Virus
Howell, M. D., Gallo, R. L., Boguniewicz, M., Jones, J. F., Wong, C., Streib, J. E., & Leung, D. Y. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.006 · Cited by 335
Hammarlund, E., Lewis, M. W., Carter, S. V., Amanna, I., Hansen, S. G., Strelow, L. I., Wong, S. W., Yoshihara, P., Hanifin, J. M., & Slifka, M. K. (2005) · Nature Medicine · doi:10.1038/nm1273 · Cited by 331
Zaucha, G. M., Jahrling, P. B., Geisbert, T. W., Swearengen, J. R., & Hensley, L. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780373 · Cited by 325
Lin, C.-L., Chung, C.-S., Heine, H. G., & Chang, W. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3353-3365.2000 · Cited by 322
Encoding of a Homolog of the IFN-γ Receptor by Myxoma Virus
Upton, C., Mossman, K., & McFadden, G. (1992) · Science · doi:10.1126/science.1455233 · Cited by 304
Multiple lineages of monkeypox virus detected in the United States, 2021–2022
Gigante, C. M., Korber, B., Seabolt, M. H., Wilkins, K., Davidson, W., Rao, A. K., Zhao, H., Smith, T. G., Hughes, C. M., Minhaj, F., et al. (2022) · Science · doi:10.1126/science.add4153 · Cited by 301
Monkeypox virus and insights into its immunomodulatory proteins
Weaver, J. R., & Isaacs, S. N. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00691.x · Cited by 295
Hsiao, J.-C., Chung, C.-S., & Chang, W. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8750-8761.1999 · Cited by 282
Vaccinia virus vaccines: Past, present and future
Jacobs, B. L., Langland, J. O., Kibler, K. V., Denzler, K. L., White, S. D., Holechek, S. A., Wong, S., Huynh, T., & Baskin, C. R. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.06.006 · Cited by 279
Vance, R. E., Jamieson, A. M., & Raulet, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1801 · Cited by 238
Granzyme B Is Inhibited by the Cowpox Virus Serpin Cytokine Response Modifier A
Quan, L. T., Caputo, A., Bleackley, R. C., Pickup, D. J., & Salvesen, G. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10377 · Cited by 234
Cho, C. T., & Wenner, H. A. (1973) · Bacteriological Reviews · doi:10.1128/br.37.1.1-18.1973 · Cited by 229
ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile
Nalca, A., & Zumbrun, E. E. (2010) · Drug Design, Development and Therapy · doi:10.2147/dddt.s3687 · Cited by 223
Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021
Hobson, G., Adamson, J. P., Adler, H., Firth, R., Gould, S., Houlihan, C. F., Johnson, C., Porter, D., Rampling, T., Ratcliffe, L., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.32.2100745 · Cited by 204
Adaptive immune responses mediated by natural killer cells
Paust, S., Senman, B. C., & von Andrian, U. H. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00906.x · Cited by 199
Wolffe, E. J., Vijaya, S., & Moss, B. (1995) · Virology · doi:10.1006/viro.1995.1378 · Cited by 197
Hu, F.-Q., Smith, C. A., & Pickup, D. J. (1994) · Virology · doi:10.1006/viro.1994.1539 · Cited by 193
The global eradication of smallpox
Strassburg, M. A. (1982) · American Journal of Infection Control · doi:10.1016/0196-6553(82)90003-7 · Cited by 193
Mulkey, S. B., Arroyave-Wessel, M., Peyton, C., Bulas, D. I., Fourzali, Y., Jiang, J., Russo, S., McCarter, R., Msall, M. E., du Plessis, A. J., et al. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.5204 · Cited by 185
Kelley, C. F., Kraft, C. S., de Man, T. J., Duphare, C., Lee, H.-W., Yang, J., Easley, K. A., Tharp, G. K., Mulligan, M. J., Sullivan, P. S., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.97 · Cited by 184
Monkeypox outbreaks outside endemic regions: scientific and social priorities
Zumla, A. I., Valdoleiros, S. R., Haider, N., Asogun, D., Ntoumi, F., Petersen, E., & Kock, R. A. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00354-1 · Cited by 184
A Poxvirus Protein That Binds to and Inactivates IL-18, and Inhibits NK Cell Response
Born, T. L., Morrison, L. A., Esteban, D. J., VandenBos, T., Thebeau, L. G., Chen, N., Spriggs, M. K., Sims, J. E., & Buller, R. M. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3246 · Cited by 182
Cidofovir Activity against Poxvirus Infections
Andrei, G., & Snoeck, R. (2010) · Viruses · doi:10.3390/v2122803 · Cited by 181
CD4 memory T cells: What are they and what can they do?
MacLeod, M. K. L., Clambey, E. T., Kappler, J. W., & Marrack, P. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.02.006 · Cited by 180
The Vaccinia Virus K1L Gene Product Inhibits Host NF-κB Activation by Preventing IκBα Degradation
Shisler, J. L., & Jin, X.-L. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3553-3560.2004 · Cited by 177
Protein composition of the vaccinia virus mature virion
Resch, W., Hixson, K. K., Moore, R. J., Lipton, M. S., & Moss, B. (2007) · Virology · doi:10.1016/j.virol.2006.08.025 · Cited by 175
Dai, P., Wang, W., Cao, H., Avogadri, F., Dai, L., Drexler, I., Joyce, J. A., Li, X.-D., Chen, Z., Merghoub, T., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003989 · Cited by 172
Jahrling, P. B., Hensley, L. E., Martinez, M. J., LeDuc, J. W., Rubins, K. H., Relman, D. A., & Huggins, J. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405954101 · Cited by 171
Karem, K. L., Reynolds, M., Hughes, C., Braden, Z., Nigam, P., Crotty, S., Glidewell, J., Ahmed, R., Amara, R., & Damon, I. K. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00148-07 · Cited by 170
Membrane fusion during poxvirus entry
Moss, B. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.07.015 · Cited by 170
Graham, S. C., Bahar, M. W., Cooray, S., Chen, R. A.-J., Whalen, D. M., Abrescia, N. G. A., Alderton, D., Owens, R. J., Stuart, D. I., Smith, G. L., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000128 · Cited by 168
Hammarlund, E., Dasgupta, A., Pinilla, C., Norori, P., Früh, K., & Slifka, M. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800589105 · Cited by 165
A Prospective Study of Serum Antibody and Protection Against Smallpox
Mack, T. M., Noble, J., & Thomas, D. B. (1972) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1972.21.214 · Cited by 158
Hijano, D. R., Vu, L. D., Kauvar, L. M., Tripp, R. A., Polack, F. P., & Cormier, S. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00566 · Cited by 155
Cohen, C. A., Li, A. P. Y., Hachim, A., Hui, D. S. C., Kwan, M. Y. W., Tsang, O. T., Chiu, S. S. S., Chan, W. H., Yau, Y. S., Kavian, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24938-4 · Cited by 152
A Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease
Fang, M., Lanier, L. L., & Sigal, L. J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040030 · Cited by 151
Ebola ça suffit ring vaccination trial consortium (2015) · BMJ · doi:10.1136/bmj.h3740 · Cited by 150
Chiu, W.-L., Lin, C.-L., Yang, M.-H., Tzou, D. M., & Chang, W. (2006) · Journal of Virology · doi:10.1128/jvi.02302-06 · Cited by 148
Immunopathogenesis of poxvirus infections: forecasting the impending storm
Stanford, M. M., McFadden, G., Karupiah, G., & Chaudhri, G. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100033 · Cited by 139
Doshi, R. H., Guagliardo, S. A. J., Doty, J. B., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2502.181222 · Cited by 139
van den Broek, M., Bachmann, M. F., Köhler, G., Barner, M., Escher, R., Zinkernagel, R., & Kopf, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.371 · Cited by 133
Granzyme B Is Critical for T Cell Receptor-Induced Cell Death of Type 2 Helper T Cells
Devadas, S., Das, J., Liu, C., Zhang, L., Roberts, A. I., Pan, Z., Moore, P. A., Das, G., & Shi, Y. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.011 · Cited by 132
FOUR GENERATIONS OF PROBABLE PERSON-TO-PERSON TRANSMISSION OF HUMAN MONKEYPOX
Jeźek, Z., Arita, I., Mutombo, M., DUNN, C., Nakano, J. H., & Szczeniowski, M. V. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114328 · Cited by 132
Chen, Z., Earl, P. L., Americo, J. L., Damon, I. K., Smith, S. K., Zhou, Y., Yu, F., Sebrell, A., Emerson, S. U., Cohen, G. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510598103 · Cited by 131
Rubins, K., Hensley, L. E., Jahrling, P. B., Whitney, A. R., Geisbert, T. W., Huggins, J. W., Owen, A. B., LeDuc, J. W., Brown, P. O., & Relman, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405759101 · Cited by 130
Estep, R. D., Messaoudi, I., O’Connor, M. A., Li, H., Sprague, J., Barron, A., Engelmann, F., Yen, B., Powers, M. F., Jones, J. M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00199-11 · Cited by 125
Africa Needs a New Public Health Order to Tackle Infectious Disease Threats
Nkengasong, J. N., & Tessema, S. K. (2020) · Cell · doi:10.1016/j.cell.2020.09.041 · Cited by 123
NFκB inhibitors: Strategies from poxviruses
Mohamed, M. R., & McFadden, G. (2009) · Cell Cycle · doi:10.4161/cc.8.19.9683 · Cited by 121
CD94 Is Essential for NK Cell-Mediated Resistance to a Lethal Viral Disease
Fang, M., Orr, M. T., Spee, P., Egebjerg, T., Lanier, L. L., & Sigal, L. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.015 · Cited by 120
Stabenow, J. M., Buller, R. M. L., Schriewer, J. M., West, C. L., Sagartz, J. E., & Parker, S. (2010) · Journal of Virology · doi:10.1128/jvi.02012-09 · Cited by 118
The Use of Vaccinia Hyperimmune Gammaglobulin in the Prophylaxis of Smallpox
Kempe, C. H., Bowles, C., Meiklejohn, G., Berge, T. O., Saint-Vincent, L., Babu, B. V. S., Govindarajan, S., Ratnakannan, N. R., Downie, A. W., & Murthy, V. R. (2015) · Association Internationale des Soci�t�s de Microbiologie · doi:10.1159/000389848 · Cited by 113
Ennis, F. A., Cruz, J., Demkowicz, Jr., Rothman, A. L., & McClain, D. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/340517 · Cited by 111
Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D
Campbell, J. A., Trossman, D., Yokoyama, W., & Carayannopoulos, L. (2007) · Journal of Experimental Medicine · doi:10.1084/jem.20062026 · Cited by 110
de Motes, C. M., Cooray, S., Ren, H., Almeida, G. M. D. F., McGourty, K., Bahar, M. W., Stuart, D. I., Grimes, J. M., Graham, S. C., & Smith, G. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002430 · Cited by 109
Comparison of Seroconversion in Children and Adults With Mild COVID-19
Toh, Z. Q., Anderson, J., Mazarakis, N., Neeland, M. R., Higgins, R. A., Rautenbacher, K., Dohle, K., Nguyen, J., Overmars, I., Donato, C. M., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.1313 · Cited by 109
Cytokine modulation correlates with severity of monkeypox disease in humans
Johnston, S. C., Johnson, J. C., Stonier, S. W., Lin, K. L., Kisalu, N. K., Hensley, L. E., & Rimoin, A. W. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.12.001 · Cited by 106
Khoury, G., Fromentin, R., Solomon, A., Hartogensis, W., Killian, M., Hoh, R., Somsouk, M., Hunt, P. W., Girling, V., Sinclair, E., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix039 · Cited by 103
Smallpox Vaccine Does Not Protect Macaques with AIDS from a Lethal Monkeypox Virus Challenge
Edghill‐Smith, Y., Bray, M., Whitehouse, C. A., Miller, D., Mucker, E. M., Manischewitz, J. F., King, L. R., Robert-Guroff, M., Hryniewicz, A., Venzon, D. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427265 · Cited by 102
Battle Royale: Innate Recognition of Poxviruses and Viral Immune Evasion
Yu, H., Bruneau, R. C., Brennan, G., & Rothenburg, S. (2021) · Biomedicines · doi:10.3390/biomedicines9070765 · Cited by 101
Dubois, M. E., Hammarlund, E., & Slifka, M. K. (2012) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2011.0779 · Cited by 100
Perforin-dependent CD4 + T-cell cytotoxicity contributes to control a murine poxvirus infection
Fang, M., Siciliano, N. A., Hersperger, A. R., Roscoe, F., Hu, A., Ma, X., Shamsedeen, A., Eisenlohr, L. C., & Sigal, L. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202143109 · Cited by 99
Wachsman, M., Petty, B. G., Cundy, K. C., Jaffe, H. S., Fisher, P., Pastelak, A. M., & Lietman, P. S. (1996) · Antiviral Research · doi:10.1016/0166-3542(95)00829-2 · Cited by 97
Song, H., Josleyn, N. M., Janosko, K. B., Skinner, J., Reeves, R. K., Cohen, M., Jett, C., Johnson, R., Blaney, J. E., Bollinger, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077804 · Cited by 97
Lymph node conduits transport virions for rapid T cell activation
Reynoso, G. V., Weisberg, A. S., Shannon, J. P., McManus, D. T., Shores, L., Americo, J. L., Stan, R. V., Yewdell, J. W., & Hickman, H. D. (2019) · Nature Immunology · doi:10.1038/s41590-019-0342-0 · Cited by 97
Hickman, H. D., Reynoso, G. V., Ngudiankama, B. F., Rubin, E. J., Magadán, J. G., Cush, S. S., Gibbs, J. S., Molon, B., Bronte, V., Bennink, J. R., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.01.004 · Cited by 87
Zhang, P., Jacobs, B. L., & Samuel, C. E. (2007) · Journal of Virology · doi:10.1128/jvi.01891-07 · Cited by 85
Prow, N. A., Liu, L., Nakayama, E., Cooper, T. H., Yan, K., Eldi, P., Hazlewood, J. E., Tang, B., Le, T. T., Setoh, Y. X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03662-6 · Cited by 85
Orthopoxvirus Genes That Mediate Disease Virulence and Host Tropism
Shchelkunov, S. N. (2012) · Advances in Virology · doi:10.1155/2012/524743 · Cited by 83
Poxviruses Utilize Multiple Strategies to Inhibit Apoptosis
Nichols, D., Martini, W. D., & Cottrell, J. A. (2017) · Viruses · doi:10.3390/v9080215 · Cited by 83
Xu, R.-H., Cohen, M. E., Tang, Y., Lazear, E., Whitbeck, J. C., Eisenberg, R. J., Cohen, G. H., & Sigal, L. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071854 · Cited by 79
Structure and Function of A41, a Vaccinia Virus Chemokine Binding Protein
Bahar, M. W., Kenyon, J. C., Pütz, M. M., Abrescia, N. G. A., Pease, J. E., Wise, E. L., Stuart, D. I., Smith, G. L., & Grimes, J. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040005 · Cited by 77
Immune profiles provide insights into respiratory syncytial virus disease severity in young children
Heinonen, S., Velazquez, V. M., Ye, F., Mertz, S. E., Acero‐Bedoya, S., Smith, B., Bunsow, E., García-Mauriño, C., Oliva, S., Cohen, D. M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0268 · Cited by 77
Vaccinia virus induces apoptosis of infected macrophages
Humlová, Z., Vokurka, M., Estéban, M., & Mělková, Z. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-11-2821 · Cited by 74
Dasgupta, A., Hammarlund, E., Slifka, M. K., & Früh, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1654 · Cited by 72
Keasey, S. L., Pugh, C. L., Tikhonov, A. P., Chen, G., Schweitzer, B. I., Nalça, A., & Ulrich, R. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015547 · Cited by 72
Regulation and consequences of monocytosis
Dutta, P., & Nahrendorf, M. (2014) · Immunological Reviews · doi:10.1111/imr.12219 · Cited by 72
Liu, L., Xu, Z., Fuhlbrigge, R. C., Peña‐Cruz, V., Lieberman, J., & Kupper, T. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7363-7370.2005 · Cited by 71
Byun, M., Verweij, M. C., Pickup, D. J., Wiertz, E. J. H. J., Hansen, T. H., & Yokoyama, W. M. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.09.012 · Cited by 71
Fischer, M. A., Davies, M. L., Reider, I. E., Heipertz, E. L., Epler, M., Sei, J. J., Ingersoll, M. A., van Rooijen, N., Randolph, G. J., & Norbury, C. C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002374 · Cited by 67
Innate Immune Receptors as Competitive Determinants of Cell Fate
Franz, K. M., & Kagan, J. C. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.009 · Cited by 65
Surviving Mousepox Infection Requires the Complement System
Moulton, E. A., Atkinson, J. P., & Buller, R. M. L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000249 · Cited by 63
Etanercept – TNF receptor and IgG1 Fc fusion protein: is it different from other TNF blockers?
Marotte, H., & Cimaz, R. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.896334 · Cited by 62
Poxviral Strategies to Overcome Host Cell Apoptosis
Suraweera, C. D., Hinds, M. G., & Kvansakul, M. (2020) · Pathogens · doi:10.3390/pathogens10010006 · Cited by 61
Disruption of MHC Class II-Restricted Antigen Presentation by Vaccinia Virus
Li, P., Wang, N., Zhou, D., Yee, C. S. K., Chang, C., Brutkiewicz, R. R., & Blum, J. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6481 · Cited by 60
Human CD4+ T Cell Epitopes from Vaccinia Virus Induced by Vaccination or Infection
Calvo‐Calle, J. M., Strug, I., Nastke, M.-D., Baker, S. P., & Stern, L. J. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030144 · Cited by 60
Poxvirus semaphorin A39R inhibits phagocytosis by dendritic cells and neutrophils
Walzer, T., Galibert, L., & Smedt, T. D. (2005) · European Journal of Immunology · doi:10.1002/eji.200425669 · Cited by 58
Earl, P. L., Americo, J. L., & Moss, B. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008505 · Cited by 58
Jayaraman, A., Jackson, D. J., Message, S. D., Pearson, R. M., Aniscenko, J., Caramori, G., Mallia, P., Papi, A. A., Shamji, B. W. H., Edwards, M. R., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.2 · Cited by 57
Ruiz-Argüello, M. B., Smith, V. P., Campanella, G. S. V., Baleux, F., Arenzana‐Seisdedos, F., Luster, A. D., & Alcamí, A. (2007) · Journal of Virology · doi:10.1128/jvi.02111-07 · Cited by 57
Genome Scale Patterns of Recombination between Coinfecting Vaccinia Viruses
Qin, L., & Evans, D. H. (2014) · Journal of Virology · doi:10.1128/jvi.00022-14 · Cited by 57
Deng, L., Dai, P., Parikh, T., Cao, H., Bhoj, V. G., Sun, Q., Chen, Z. J., Merghoub, T., Houghton, A. N., & Shuman, S. (2008) · Journal of Virology · doi:10.1128/jvi.01305-08 · Cited by 55
Beauchamp, N. M., Busick, R. Y., & Alexander‐Miller, M. A. (2010) · Journal of Virology · doi:10.1128/jvi.00892-10 · Cited by 51
Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones
Littaua, R. A., Takeda, A., Cruz, J., & Ennis, F. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2274-2280.1992 · Cited by 50
Midgley, C. M., Pütz, M. M., Weber, J. N., & Smith, G. L. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/004440-0 · Cited by 47
Mikulak, J., Vito, C. D., Zaghi, E., & Mavilio, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00314 · Cited by 46
Primary Human Macrophages Serve as Vehicles for Vaccinia Virus Replication and Dissemination
Byrd, D., Shepherd, N., Lan, J., Hu, N., Amet, T., Yang, K., Desai, M., & Yu, Q. (2014) · Journal of Virology · doi:10.1128/jvi.03726-13 · Cited by 43
Munier, C. M. L., van Bockel, D. J., Bailey, M., Ip, S., Xu, Y., Alcântara, S., Liu, S. M., Denyer, G. S., Kaplan, W. H., Suzuki, K., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.009 · Cited by 41
Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response
Pilato, M. D., Mejías‐Pérez, E., Sorzano, C. Ó. S., & Estéban, M. (2017) · Journal of Virology · doi:10.1128/jvi.00575-17 · Cited by 41
Ryan, M. A. K., Seward, J. F., & Smallpox Vaccine in Pregnancy Registry Team (2008) · Clinical Infectious Diseases · doi:10.1086/524744 · Cited by 40
Plasmodium co-infection protects against chikungunya virus-induced pathologies
Teo, T., Lum, F., Ghaffar, K. A., Chan, Y., Amrun, S. N., Tan, J. J. L., Lee, C. Y., Chua, T., Carissimo, G., Lee, W. W. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06227-9 · Cited by 39
Self-citationMucker, E. M., Thiele-Suess, C., Baumhof, P., & Hooper, J. W. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.05.025 · Cited by 39
Teo, T., Howland, S. W., Claser, C., Gun, S. Y., Poh, C. M., Lee, W. W. L., Lum, F., Ng, L. F. P., & Rénia, L. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707885 · Cited by 37
Self-citationVeyer, D. L., de Motes, C. M., Sumner, R. P., Ludwig‐Begall, L. F., Johnson, B. F., & Smith, G. L. (2014) · Journal of General Virology · doi:10.1099/vir.0.068833-0 · Cited by 34
T‐Cell epitope discovery for variola and vaccinia viruses
Kennedy, R. B., & Poland, G. A. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.527 · Cited by 33
Molero-Abraham, M., Glutting, J.-P., Flower, D. R., Lafuente, E. M., & Reche, P. A. (2015) · Journal of Immunology Research · doi:10.1155/2015/738020 · Cited by 31
Zhao, Y., Adams, Y. F., & Croft, M. (2011) · Viral Immunology · doi:10.1089/vim.2011.0020 · Cited by 31
A systemic macrophage response is required to contain a peripheral poxvirus infection
Davies, M. L., Parekh, N. J., Kaminsky, L. W., Soni, C., Reider, I. E., Krouse, T. E., Fischer, M. A., van Rooijen, N., Rahman, Z. S. M., & Norbury, C. C. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006435 · Cited by 26
Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques
Walsh, S. R., Gillis, J. M., Peters, B., Mothé, B. R., Sidney, J., Sette, A., & Johnson, R. P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.077 · Cited by 24
Bloomer, D. T., Kitevska, T., Pantaki-Eimany, D., Ji, Y., Miles, M. A., Heras, B., & Hawkins, C. J. (2019) · Biochemical Journal · doi:10.1042/bcj20190202 · Cited by 24
The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins
Kennedy, R. B., & Poland, G. A. (2010) · Virology · doi:10.1016/j.virol.2010.09.013 · Cited by 23
Immune Privilege Furnishes a Niche for Latent Infection
Forrester, J. V., Mölzer, C., & Kuffová, L. (2022) · Frontiers in Ophthalmology · doi:10.3389/fopht.2022.869046 · Cited by 20
Pugh, C. L., Keasey, S. L., Korman, L., Pittman, P. R., & Ulrich, R. G. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00035-14 · Cited by 19
Vaccinia Virus Infection Inhibits Skin Dendritic Cell Migration to the Draining Lymph Node
Aggio, J. B., Krmeská, V., Ferguson, B. J., Wowk, P. F., & Rothfuchs, A. G. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000928 · Cited by 16
γδT Cells Are Required for CD8+ T Cell Response to Vaccinia Viral Infection
Dai, R., Huang, X., & Yang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.727046 · Cited by 15
Sukhumvittaya, S., Ampol, S., Pattanapanyasat, K., & Kantakamalakul, W. (2016) · Advances in Microbiology · doi:10.4236/aim.2016.63017 · Cited by 7
Editorial: Lymphocyte Functional Crosstalk and Regulation
Srivastava, R. M., Marincola, F. M., & Shanker, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02916 · Cited by 5
Systems Immunology, Adaptive Immune Response to HIV Infection
Yohannes, E., & Chance, M. R. (2013) · Springer eBooks · doi:10.1007/978-1-4419-9863-7_104 · Cited by 2
Cited by
Mpox virus infection and drug treatment modelled in human skin organoids
Li, P., Pachis, S. T., Xu, G., Schraauwen, R., Incitti, R., de Vries, A. C., Bruno, M. J., Peppelenbosch, M. P., Alam, I., Raymond, K., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01489-6 · Cited by 77
“Over past decades, MPXV endemically circulates in tropical regions of African countries, predominantly in Central Africa 2 .”
BackgroundStructural basis for the assembly of the DNA polymerase holoenzyme from a monkeypox virus variant
Li, Y., Shen, Y., Hu, Z., & Yan, R. (2023) · Science Advances · doi:10.1126/sciadv.adg2331 · Cited by 31
Mangiferin and Taurine Ameliorate MSRV Infection by Suppressing NF-κB Signaling
Dai, C., Yu, L., Wang, Z., Deng, P., Li, L., Gu, Z., He, X., Wang, J., & Yuan, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05146-22 · Cited by 21
(2024) · doi:10.7554/elife.100545 · Cited by 16
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2
Karim, M., Mishra, M., Lo, C.-W., Saul, S., Cagirici, H. B., Gourdelier, M., Ghita, L., Ojha, A., Tran, D. H. N., Agrawal, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61759-1 · Cited by 16
Metadata
- Authors
- Lum, F.-M., Torres-Ruesta, A., Tay, M. Z., Lin, R. T. P., Lye, D. C., Rénia, L., & Ng, L. F. P.
- Venue
- Nature Reviews Immunology
- Published
- 2022-09-05
- Volume
- 22
- Issue
- 10
- Pages
- 597-613
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W4294637087
- Cited by
- 541
- References
- 160
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.